Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Jubilant Life Sciences' Pantoprazole Sodium Delayed Release Tablets 20mg & 40mg.
Subscribe to our email newsletter
Pantoprazole Sodium Delayed Release Tablets 20mg & 40mg are the generic version of Protonix of Wyeth.
Pantoprazole Sodium tablets are indicated for the short-term treatment of erosive esophagitis linked with gastro esophageal reflux disease, maintenance of healing of erosive esophagitis and pathological hypersecretory conditions including Zollinger-Ellison Syndrome.
The drug will be marketed by the company’s US subsidiary Jubilant Cadista Pharmaceuticals under its own label.